Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Managing risk of pregnancy
The teratogenicity of isotretinoin has been known since isotretinoin was first introduced for acne treatment. Because of this, Patricia Farris, M.D., a dermatologist based in Metairie, La., not only insists on adequate birth control use but adds that the patient must be open to the possibility that if her birth control fails that she would terminate the pregnancy.
Related Videos
Related Content
